Abstract

IntroductionPercutaneous transhepatic portal embolization is often performed to expand the indications for hepatic resection. Various etiologies of hepatic artery pseudoaneurysm have been reported, but regardless of the etiology, hepatic artery pseudoaneurysm is usually managed with an endovascular approach or open surgery, depending on the location and clinical symptomatology. However, it is difficult to manage hepatic artery pseudoaneurysm after percutaneous transhepatic portal embolization, since embolization of the hepatic artery may cause hepatic infarctionCase presentationA 58-year-old Japanese man with hilar bile duct cancer underwent percutaneous transhepatic portal embolization to expand the indication for hepatic resection. Two days after percutaneous transhepatic portal embolization, our patient suddenly complained of abdominal pain. Contrast-enhanced computed tomography confirmed a pseudoaneurysm arising from a segmental branch of his right hepatic artery. Since embolization of the hepatic arterial branches may cause hepatic infarction, ultrasound-guided thrombin injection therapy was successfully performed for the pseudoaneurysm.ConclusionWe performed a thrombin injection instead of arterial embolization to avoid hepatic infarction. The rationale of this choice may be insufficient. However, ultrasound-guided percutaneous thrombin injection therapy may be considered as an alternative to percutaneous transarterial embolization or surgical intervention for an iatrogenic hepatic artery pseudoaneurysm.

Highlights

  • Percutaneous transhepatic portal embolization is often performed to expand the indications for hepatic resection

  • Ultrasound-guided percutaneous thrombin injection therapy may be considered as an alternative to percutaneous transarterial embolization or surgical intervention for an iatrogenic hepatic artery pseudoaneurysm

  • Various etiologies of hepatic artery pseudoaneurysm (HAP) have been reported, but regardless of the etiology, HAP is usually managed with an endovascular approach or open surgery, depending on the location and clinical symptomatology

Read more

Summary

Conclusion

A HAP is one of the possible complications following PTPE. Such a complication will be managed by an endovascular approach. We performed thrombin injection instead of arterial embolization to avoid hepatic infarction. The rationale for this choice may be insufficient. US-guided percutaneous thrombin injection therapy may be considered as an alternative to TAE or surgical intervention for an iatrogenic HAP. Author details 1Department of Diagnostic and Interventional Radiology, Gunma University Hospital, Maebashi, Gunma, Japan. Authors’ contributions HT reviewed relevant literature and drafted the manuscript. All authors provided clinical expertise and participated in drafting the manuscript. All authors read and approved the final manuscript. Competing interests The authors declare that they have no competing interests

Introduction
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call